 |  |  |  |  |
| | | | |
Our unique structure and synergy enables the cost effective and efficient use of the available funds. We have a flat and efficient infrastructure so that we can use funds from our philanthropic donators, sponsors and investors specifically for project management, approval procedures, production and distribution.
The company is set up to earn profit and be socially sustainable.
A predetermined portion of revenues from this company is re-invested yearly into our Foundation.
A close Relationship between the Company and the Foundation allows for optimal Transfer of knowledge and an efficient Structure enables us to bring new medications to the market quickly.
We are working on a Research & Industry Partnership Network and preparing a platform for new Ideas and Projects.
Our goal is to create new medications for people with Rare Diseases by cooperating with partners and sharing knowledge.